2.7.11.19 Acidosis, Lactic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6679873&form=6&db=m Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. causal interaction,unassigned 3,0 2.7.11.19 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6184993&form=6&db=m In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure. causal interaction,diagnostic usage,unassigned 1,2,0 2.7.11.19 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7019564&form=6&db=m Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 2.7.11.19 Acute Kidney Injury http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7395771&form=6&db=m Enhanced proteolytic activity--cause of protein catabolism in acute renal failure. diagnostic usage,ongoing research,unassigned 4,1,0 2.7.11.19 Alzheimer Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8395566&form=6&db=m Phosphoprotein phosphatase activities in Alzheimer disease brain. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,3,3,1 2.7.11.19 Bradycardia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14696860&form=6&db=m Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency. causal interaction,unassigned 2,0 2.7.11.19 carboxypeptidase t deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2156480&form=6&db=m Metabolic causes of myoglobinuria. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4300688&form=6&db=m Glycogen storage in a hepatoma: dephosphophosphorylase kinase defect. unassigned - 2.7.11.19 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26048985&form=6&db=m Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes. ongoing research,unassigned 2,0 2.7.11.19 Cardiomyopathies http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10368461&form=6&db=m Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Cardiomyopathy, Hypertrophic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8236826&form=6&db=m Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Cardiomyopathy, Hypertrophic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10368461&form=6&db=m Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Colorectal Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28275865&form=6&db=m Phosphorylase kinase ? affects colorectal cancer cell growth and represents a novel prognostic biomarker. diagnostic usage,ongoing research,unassigned 3,4,0 2.7.11.19 Cystic Fibrosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16887929&form=6&db=m Peptide microarray analysis of substrate specificity of the transmembrane Ser/Thr kinase KPI-2 reveals reactivity with cystic fibrosis transmembrane conductance regulator and phosphorylase. therapeutic application,unassigned 1,0 2.7.11.19 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21132776&form=6&db=m Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: The role of water molecules examined. therapeutic application,unassigned 3,0 2.7.11.19 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21287607&form=6&db=m Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: the role of water molecules examined. therapeutic application,unassigned 3,0 2.7.11.19 Diabetes Mellitus, Type 2 http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26364215&form=6&db=m An evaluation of indirubin analogues as phosphorylase kinase inhibitors. causal interaction,therapeutic application,unassigned 1,2,0 2.7.11.19 Fanconi Syndrome http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10987651&form=6&db=m A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. causal interaction,unassigned 1,0 2.7.11.19 glycogen phosphorylase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8655128&form=6&db=m Genetic deficiencies of the glycogen phosphorylase system. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=168880&form=6&db=m Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 4,1,4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1372435&form=6&db=m cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis. causal interaction,ongoing research,unassigned 1,2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1505214&form=6&db=m Regional mapping of a liver alpha-subunit gene of phosphorylase kinase (PHKA) to the distal region of human chromosome Xp. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1674721&form=6&db=m Mapping of the gene for X-linked liver glycogenosis due to phosphorylase kinase deficiency to human chromosome region Xp22. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2122110&form=6&db=m Molecular genetics of phosphorylase kinase: cDNA cloning, chromosomal mapping and isoform structure. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2205434&form=6&db=m [A case of glycogen storage myopathy with acute heart failure] causal interaction,unassigned 1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2303074&form=6&db=m The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2387090&form=6&db=m Families with X-linked liver glycogenosis due to phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2606129&form=6&db=m Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle. unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3093350&form=6&db=m The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa. causal interaction,diagnostic usage,therapeutic application,unassigned 1,2,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3116329&form=6&db=m Phosphorylase b kinase deficiency in glycogenosis type VIII: differentiation of different phenotypes and heterozygotes by erythrocyte enzyme assay. diagnostic usage,ongoing research,unassigned 3,2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3116330&form=6&db=m Phosphorylase kinase in leukocytes and erythrocytes of a patient with glycogen storage disease type IX. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3459948&form=6&db=m Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3918928&form=6&db=m Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: a new type of glycogen storage disease. causal interaction,therapeutic application,unassigned 1,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4322108&form=6&db=m Loss of cyclic 3'5'-AMP dependent kinase and reduction of phosphorylase kinase in skeletal muscle of a girl with deactivated phosphorylase and glycogenosis of liver and muscle. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4518931&form=6&db=m Glycogen storage disease type IX: benign glycogenosis of liver and hepatic phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5270452&form=6&db=m Liver glycogenosis and phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5270453&form=6&db=m Liver glycogenosis and phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5306139&form=6&db=m X-chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6213881&form=6&db=m Fatal infantile glycogen storage disease: deficiency of phosphofructokinase and phosphorylase b kinase. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6241011&form=6&db=m [Genetic heterogeneity and the diagnosis of hepatic glycogenoses] unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6304667&form=6&db=m Glycogen storage disease. Studies related to the mechanism of glycogenosome formation. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6424667&form=6&db=m A new type of glycogen storage disease caused by deficiency of cardiac phosphorylase kinase. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6574020&form=6&db=m Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation. causal interaction,therapeutic application,unassigned 1,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6938920&form=6&db=m Glycogenosis due to liver and muscle phosphorylase kinase deficiency. unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6962066&form=6&db=m Phosphorylase kinase deficiency: severe glycogen storage disease with evidence of autosomal recessive mode of inheritance. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6962087&form=6&db=m Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance. unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7549948&form=6&db=m Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit (PHKA2) and identification of a missense mutation of the PHKA2 gene in a family with liver phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7562285&form=6&db=m Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7711737&form=6&db=m Mutations in the phosphorylase kinase gene PHKA2 are responsible for X-linked liver glycogen storage disease. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7874115&form=6&db=m Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7959740&form=6&db=m Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2). causal interaction,ongoing research,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8148232&form=6&db=m In situ 13C NMR quantification of hepatic glycogen. therapeutic application,unassigned 2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8236826&form=6&db=m Fatal infantile hypertrophic cardiomyopathy secondary to deficiency of heart specific phosphorylase b kinase. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8298647&form=6&db=m Phosphorylase kinase deficiency in I-strain mice is associated with a frameshift mutation in the alpha subunit muscle isoform. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8362811&form=6&db=m Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency. unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8385243&form=6&db=m [Molecular pathology of hepatic glycogen storage disease] unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8518797&form=6&db=m X-linked liver glycogenosis: localization and isolation of a candidate gene. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8530014&form=6&db=m Human cDNA encoding the muscle isoform of the phosphorylase kinase gamma subunit (PHKG1). causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8655128&form=6&db=m Genetic deficiencies of the glycogen phosphorylase system. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8733133&form=6&db=m X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase. causal interaction,unassigned 2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8733134&form=6&db=m Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8795843&form=6&db=m Metabolic myopathies. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8896567&form=6&db=m Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9215682&form=6&db=m Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9384616&form=6&db=m Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9402963&form=6&db=m Phosphorylase-kinase-deficient liver glycogenosis with an unusual biochemical phenotype in blood cells associated with a missense mutation in the beta subunit gene (PHKB). causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9533876&form=6&db=m Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease. causal interaction,unassigned 1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9600238&form=6&db=m Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10368461&form=6&db=m Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10905889&form=6&db=m Phosphorylase kinase deficient liver glycogenosis: progression to cirrhosis in infancy associated with PHKG2 mutations (H144Y and L225R) causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10987651&form=6&db=m A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. causal interaction,unassigned 1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12825073&form=6&db=m Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases. causal interaction,diagnostic usage,unassigned 4,2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15877279&form=6&db=m Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17581768&form=6&db=m Identification of Alu-mediated, large deletion-spanning introns 19-26 in PHKA2 in a patient with X-linked liver glycogenosis (hepatic phosphorylase kinase deficiency). unassigned - 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17667862&form=6&db=m Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17689125&form=6&db=m Glycogen storage disease type IX: High variability in clinical phenotype. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18950708&form=6&db=m 3D mapping of glycogenosis-causing mutations in the large regulatory alpha subunit of phosphorylase kinase. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21131218&form=6&db=m Novel mutations in PHKA2 gene in glycogen storage disease type IX patients from Hong Kong, China. causal interaction,diagnostic usage,unassigned 3,4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21844581&form=6&db=m A novel PHKA2 gross deletion mutation in a Korean patient with X-linked liver glycogenosis type I. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22238410&form=6&db=m Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease? causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24326380&form=6&db=m Novel PHKG2 mutation causing GSD IX with prominent liver disease: report of three cases and review of literature. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24389071&form=6&db=m Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26157701&form=6&db=m Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26364215&form=6&db=m An evaluation of indirubin analogues as phosphorylase kinase inhibitors. causal interaction,therapeutic application,unassigned 1,2,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29360628&form=6&db=m PHKG2 mutation spectrum in glycogen storage disease type IXc: a case report and review of the literature. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30925902&form=6&db=m A novel PHKA2 mutation in a Chinese child with glycogen storage disease type IXa: a case report and literature review. causal interaction,unassigned 3,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32244026&form=6&db=m Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32660786&form=6&db=m An unusual case of recurrent episodes of muscle weakness: Co-occurrence of Andersen-Tawil syndrome and glycogen storage disease type IXd. causal interaction,diagnostic usage,therapeutic application,unassigned 4,2,1,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32697758&form=6&db=m Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34083142&form=6&db=m Characterization of liver GSD IX ?2 pathophysiology in a novel Phkg2-/- mouse model. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease Type II http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8733133&form=6&db=m X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase. causal interaction,unassigned 2,0 2.7.11.19 Glycogen Storage Disease Type II http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9382133&form=6&db=m Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 2.7.11.19 Glycogen Storage Disease Type IV http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6304667&form=6&db=m Glycogen storage disease. Studies related to the mechanism of glycogenosome formation. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Glycogen Storage Disease Type V http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8655128&form=6&db=m Genetic deficiencies of the glycogen phosphorylase system. causal interaction,unassigned 4,0 2.7.11.19 Glycogen Storage Disease Type V http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27399985&form=6&db=m Substrate kinetics in patients with disorders of skeletal muscle metabolism. causal interaction,diagnostic usage,unassigned 1,3,0 2.7.11.19 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2252364&form=6&db=m Adult phosphorylase b kinase deficiency. causal interaction,ongoing research,therapeutic application,unassigned 2,3,2,0 2.7.11.19 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7957405&form=6&db=m Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,3,0 2.7.11.19 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27207549&form=6&db=m Discovery of a Genetic Metabolic Cause for Mauriac Syndrome in Type 1 Diabetes. therapeutic application,unassigned 1,0 2.7.11.19 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28283841&form=6&db=m Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,1,0 2.7.11.19 Hepatomegaly http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32697758&form=6&db=m Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene. causal interaction,unassigned 4,0 2.7.11.19 Hyperlipidemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28283841&form=6&db=m Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,1,0 2.7.11.19 Hyperthyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6306261&form=6&db=m Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,1,1,1 2.7.11.19 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7562285&form=6&db=m Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. unassigned - 2.7.11.19 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12930917&form=6&db=m Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. causal interaction,unassigned 4,0 2.7.11.19 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28283841&form=6&db=m Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,1,0 2.7.11.19 Hypoglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34117828&form=6&db=m PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only. diagnostic usage,unassigned 1,0 2.7.11.19 Hypothyroidism http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2774570&form=6&db=m Phosphorylase a formation in protein-glycogen particles isolated from fast-twitch muscle of euthyroid and hypothyroid rats. causal interaction,therapeutic application,unassigned 1,1,0 2.7.11.19 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12930917&form=6&db=m Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. causal interaction,unassigned 4,0 2.7.11.19 Liver Cirrhosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32697758&form=6&db=m Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene. causal interaction,unassigned 4,0 2.7.11.19 Liver Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31754332&form=6&db=m Phosphorylase Kinase ? Represents a Novel Prognostic Biomarker and Inhibits Malignant Phenotypes of Liver Cancer Cell. ongoing research,therapeutic application,unassigned 2,1,0 2.7.11.19 Melanoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34199079&form=6&db=m Preliminary Study: Proteomic Profiling Uncovers Potential Proteins for Biomonitoring Equine Melanocytic Neoplasm. causal interaction,unassigned 1,0 2.7.11.19 Muscle Cramp http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2252364&form=6&db=m Adult phosphorylase b kinase deficiency. causal interaction,ongoing research,therapeutic application,unassigned 2,3,2,0 2.7.11.19 Muscle Cramp http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12825073&form=6&db=m Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases. causal interaction,diagnostic usage,unassigned 4,2,0 2.7.11.19 Muscle Cramp http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33799212&form=6&db=m A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. causal interaction,unassigned 4,0 2.7.11.19 Muscle Weakness http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33799212&form=6&db=m A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. causal interaction,unassigned 4,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3221237&form=6&db=m Phosphorylase kinase activities in damaged mouse skeletal muscles. diagnostic usage,ongoing research,unassigned 1,2,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6285226&form=6&db=m Infantile glycogen storage myopathy in a girl with phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6574020&form=6&db=m Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation. causal interaction,therapeutic application,unassigned 1,1,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6820425&form=6&db=m A female case of glycogen storage myopathy due to phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9731190&form=6&db=m A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy. unassigned - 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15637709&form=6&db=m Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 Muscular Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33799212&form=6&db=m A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. causal interaction,unassigned 4,0 2.7.11.19 Myalgia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2128163&form=6&db=m Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency. unassigned - 2.7.11.19 Myalgia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33799212&form=6&db=m A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. causal interaction,unassigned 4,0 2.7.11.19 Myoglobinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2156480&form=6&db=m Metabolic causes of myoglobinuria. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 Myoglobinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8795843&form=6&db=m Metabolic myopathies. causal interaction,unassigned 4,0 2.7.11.19 Myoglobinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12825073&form=6&db=m Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases. causal interaction,diagnostic usage,unassigned 4,2,0 2.7.11.19 Myoglobinuria http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33799212&form=6&db=m A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency. causal interaction,unassigned 4,0 2.7.11.19 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22179836&form=6&db=m Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish. causal interaction,unassigned 4,0 2.7.11.19 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25051373&form=6&db=m KIAA1199 interacts with glycogen phosphorylase kinase ?-subunit (PHKB) to promote glycogen breakdown and cancer cell survival. unassigned - 2.7.11.19 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25202906&form=6&db=m Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches. causal interaction,diagnostic usage,unassigned 3,1,0 2.7.11.19 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26364215&form=6&db=m An evaluation of indirubin analogues as phosphorylase kinase inhibitors. causal interaction,therapeutic application,unassigned 1,2,0 2.7.11.19 Pancreatitis, Acute Necrotizing http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7019564&form=6&db=m Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 2.7.11.19 Pancreatitis, Chronic http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7019564&form=6&db=m Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 2.7.11.19 phosphoglycerate kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2156480&form=6&db=m Metabolic causes of myoglobinuria. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 phosphoglycerate mutase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2156480&form=6&db=m Metabolic causes of myoglobinuria. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=168880&form=6&db=m Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 4,1,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=207857&form=6&db=m Comparison of the mechanism of isoproterenol-stimulated glycogenolysis in skeletal muscle of normal and phosphorylase kinase-deficient mice (I strain). causal interaction,ongoing research,unassigned 4,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=228813&form=6&db=m [Regulation of glycogen metabolism in the liver and hepatic glycogenosis due to phosphorylase system deficiency] causal interaction,diagnostic usage,unassigned 1,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=739734&form=6&db=m Hepatic phosphorylase kinase deficiency: a survey of phosphorylase kinase activity in erythrocytes. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=820556&form=6&db=m The molecular basis of skeletal muscle phosphorylase kinase deficiency. causal interaction,diagnostic usage,unassigned 1,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=978457&form=6&db=m Stimulation of glycogenolysis by beta adrenergic agonists in skeletal muscle of mice with the phosphorylase kinase deficiency mutation (I strain). causal interaction,ongoing research,unassigned 1,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1203056&form=6&db=m The phosphorylase kinase deficiency (Phk) locus in the mouse: evidence that the mutant allele codes for an enzyme with an abnormal structure. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1372435&form=6&db=m cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis. causal interaction,ongoing research,unassigned 1,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1645631&form=6&db=m Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. causal interaction,diagnostic usage,unassigned 1,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1674721&form=6&db=m Mapping of the gene for X-linked liver glycogenosis due to phosphorylase kinase deficiency to human chromosome region Xp22. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1886411&form=6&db=m Hepatic phosphorylase b kinase deficiency with normal enzyme activity in leukocytes and erythrocytes. diagnostic usage,ongoing research,unassigned 1,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1973380&form=6&db=m Mapping of the phosphorylase kinase alpha subunit gene on the mouse X chromosome. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2122110&form=6&db=m Molecular genetics of phosphorylase kinase: cDNA cloning, chromosomal mapping and isoform structure. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2122111&form=6&db=m Phosphorylase b kinase deficiency in man: a review. causal interaction,diagnostic usage,therapeutic application,unassigned 4,1,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2128163&form=6&db=m Myopathic evolution of an exertional muscle pain syndrome with phosphorylase b kinase deficiency. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2156480&form=6&db=m Metabolic causes of myoglobinuria. causal interaction,diagnostic usage,unassigned 4,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2252364&form=6&db=m Adult phosphorylase b kinase deficiency. causal interaction,ongoing research,therapeutic application,unassigned 2,3,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2297530&form=6&db=m Localisation of the gene encoding the catalytic gamma subunit of phosphorylase kinase to human chromosome bands 7p12-q21. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2303074&form=6&db=m The natural history of liver glycogenosis due to phosphorylase kinase deficiency: a longitudinal study of 41 patients. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2387090&form=6&db=m Families with X-linked liver glycogenosis due to phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2515373&form=6&db=m The effect of ethanol on glucose production in phosphorylase b kinase deficiency. ongoing research,therapeutic application,unassigned 3,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2602386&form=6&db=m I/Lyn mouse phosphorylase kinase deficiency: mutation disrupts expression of the alpha/alpha'-subunit mRNAs. causal interaction,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2606129&form=6&db=m Phosphorylase b kinase deficiency in a boy with glycogenosis affecting both liver and muscle. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2635861&form=6&db=m Skeletal muscle glycogen content, structure, and metabolism are normal in rats with hepatic glycogen phosphorylase kinase deficiency. ongoing research,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3116329&form=6&db=m Phosphorylase b kinase deficiency in glycogenosis type VIII: differentiation of different phenotypes and heterozygotes by erythrocyte enzyme assay. diagnostic usage,ongoing research,unassigned 3,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3148066&form=6&db=m Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3148080&form=6&db=m Enzymatic analysis in lymphocytes and erythrocytes from six patients with different phenotypes of phosphorylase kinase deficiency. diagnostic usage,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3183845&form=6&db=m Hepatic phosphorylase b kinase deficiency with normal enzyme activity in leukocytes. causal interaction,diagnostic usage,ongoing research,unassigned 1,2,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3385534&form=6&db=m Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3459948&form=6&db=m Clinical and laboratory observations in a child with hepatic phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3609320&form=6&db=m Isolation and sequence analysis of a cDNA clone encoding the entire catalytic subunit of phosphorylase kinase. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3987709&form=6&db=m Lymphocyte phosphorylase kinase activities in the sex-linked form of liver phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4198146&form=6&db=m Skeletal muscle phosphorylase kinase deficiency: detection of a protein lacking any activity in ICR-IAn mice. ongoing research,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4213608&form=6&db=m Characterization of the phosphorylase b to a converting activity in skeletal muscle extracts of mice with the phosphorylase b kinase deficiency mutation. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4356658&form=6&db=m Glycogen phosphorylase kinase deficiency: a survey of enzymes in phosphorylase activating system. causal interaction,unassigned 1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4356986&form=6&db=m The phosphorylation of troponin B by phosphorylase b kinase in skeletal muscle of mice carrying the phosphorylase b kinase deficiency gene. causal interaction,ongoing research,therapeutic application,unassigned 1,2,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4518931&form=6&db=m Glycogen storage disease type IX: benign glycogenosis of liver and hepatic phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4524311&form=6&db=m Glycogen-storage disease associated with phosphorylase kinase deficiency: evidence for X inactivation. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5270452&form=6&db=m Liver glycogenosis and phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5270453&form=6&db=m Liver glycogenosis and phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5306139&form=6&db=m X-chromosomal inheritance of liver glycogenosis with phosphorylase kinase deficiency. causal interaction,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5444101&form=6&db=m Phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6243933&form=6&db=m The autosomal form of phosphorylase kinase deficiency in man: reduced activity of the muscle enzyme. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6285226&form=6&db=m Infantile glycogen storage myopathy in a girl with phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6304667&form=6&db=m Glycogen storage disease. Studies related to the mechanism of glycogenosome formation. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6422139&form=6&db=m Glycogen phosphorylase b kinase deficiency in three siblings. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6574020&form=6&db=m Myopathy due to glycogen storage disease: pathological and biochemical studies in relation to glycogenosome formation. causal interaction,therapeutic application,unassigned 1,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6615485&form=6&db=m Glycogenolysis in liver of phosphorylase kinase-deficient rats during liver perfusion and ischaemia. causal interaction,unassigned 2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6626146&form=6&db=m The phosphorylase kinase activity of hearts from phosphorylase kinase-deficient mice. causal interaction,ongoing research,unassigned 4,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6768356&form=6&db=m Metabolic adaptation in phosphorylase kinase deficiency. Changes in metabolite concentrations during tetanic stimulation of mouse leg muscles. causal interaction,unassigned 2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6787554&form=6&db=m Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6820425&form=6&db=m A female case of glycogen storage myopathy due to phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6938920&form=6&db=m Glycogenosis due to liver and muscle phosphorylase kinase deficiency. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6962066&form=6&db=m Phosphorylase kinase deficiency: severe glycogen storage disease with evidence of autosomal recessive mode of inheritance. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6962087&form=6&db=m Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7014637&form=6&db=m Glucose homeostasis during the perinatal period in normal rats and rats with a glycogen storage disorder. ongoing research,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7295891&form=6&db=m Alkalinization of phosphorylase kinase-deficient muscle during tetanic contraction. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7447922&form=6&db=m X-linked dominant inheritance of partial phosphorylase kinase deficiency in mice. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7465553&form=6&db=m Phosphorylase kinase deficiency and decreased fat accumulation in hybrid male mice (I X C3H). unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7549948&form=6&db=m Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit (PHKA2) and identification of a missense mutation of the PHKA2 gene in a family with liver phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7562285&form=6&db=m Phosphorylase b kinase deficiency glycogenosis with cirrhosis of the liver. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7623455&form=6&db=m Factor XI and phosphorylase b kinase deficiency. diagnostic usage,ongoing research,unassigned 4,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7705849&form=6&db=m Dinucleotide repeat polymorphism within the PHKA1 gene at Xq12-q13. causal interaction,diagnostic usage,therapeutic application,unassigned 3,3,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7803079&form=6&db=m [Five cases of phosphorylase b kinase deficiency affecting muscle or liver: clinical symptoms and diagnosis] diagnostic usage,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7847371&form=6&db=m X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7874115&form=6&db=m Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7957405&form=6&db=m Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7959740&form=6&db=m Localization of a new type of X-linked liver glycogenosis to the chromosomal region Xp22 containing the liver alpha-subunit of phosphorylase kinase (PHKA2). causal interaction,ongoing research,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8051918&form=6&db=m Hepatic phosphorylase b kinase deficiency with normal enzyme activity in erythrocytes and muscle. diagnostic usage,ongoing research,unassigned 1,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8145916&form=6&db=m Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency. causal interaction,diagnostic usage,unassigned 4,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8148232&form=6&db=m In situ 13C NMR quantification of hepatic glycogen. therapeutic application,unassigned 2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8298647&form=6&db=m Phosphorylase kinase deficiency in I-strain mice is associated with a frameshift mutation in the alpha subunit muscle isoform. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8362811&form=6&db=m Fanconi's syndrome with hepatorenal glycogenosis associated with phosphorylase b kinase deficiency. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8385243&form=6&db=m [Molecular pathology of hepatic glycogen storage disease] unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8655128&form=6&db=m Genetic deficiencies of the glycogen phosphorylase system. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8733134&form=6&db=m Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8830182&form=6&db=m Neonatal-onset severe recurrent hypoglycaemia in an infant with hepatic phosphorylase kinase deficiency with normal enzyme activity in erythrocytes. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8944243&form=6&db=m [Exercise intolerance caused by muscular phosphorylase kinase deficiency. Contribution of in vivo metabolic studies] causal interaction,diagnostic usage,unassigned 4,4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9215682&form=6&db=m Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB). causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9245685&form=6&db=m Autosomal recessive liver phosphorylase kinase deficiency caused by a novel splice-site mutation in the gene encoding the liver gamma subunit (PHKG2). causal interaction,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9326319&form=6&db=m Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB). causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9382133&form=6&db=m Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. causal interaction,diagnostic usage,therapeutic application,unassigned 4,3,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9384616&form=6&db=m Liver glycogenosis due to phosphorylase kinase deficiency: PHKG2 gene structure and mutations associated with cirrhosis. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9533876&form=6&db=m Unequal homologous recombination between LINE-1 elements as a mutational mechanism in human genetic disease. causal interaction,unassigned 1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9808277&form=6&db=m Metabolic causes of recurrent rhabdomyolysis. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9870210&form=6&db=m Mutational analyses in four Japanese families with X-linked liver phosphorylase kinase deficiency type 1. causal interaction,ongoing research,unassigned 4,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10368461&form=6&db=m Infantile hypertrophic cardiomyopathy of glycogenosis type IX: isolated cardiac phosphorylase kinase deficiency. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11386811&form=6&db=m Adult-onset exercise intolerance due to phosphorylase b kinase deficiency. causal interaction,unassigned 2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11596358&form=6&db=m [Phosphorylase b kinase deficiency] unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11945425&form=6&db=m Phosphorylase kinase deficiency in mice. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12862311&form=6&db=m Detection of PHKA2 gene mutation in four Japanese patients with hepatic phosphorylase kinase deficiency. causal interaction,unassigned 3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12910079&form=6&db=m [Glycogenesis due to adult phosphorylase kinase deficiency] causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12930917&form=6&db=m Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14696860&form=6&db=m Fetal bradycardia at 28 weeks of gestation associated with cardiac glycogen phosphorylase b kinase deficiency. causal interaction,unassigned 2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15637709&form=6&db=m Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. causal interaction,therapeutic application,unassigned 4,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15877279&form=6&db=m Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16151901&form=6&db=m Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17027861&form=6&db=m Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. causal interaction,ongoing research,unassigned 4,2,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17667862&form=6&db=m Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18474841&form=6&db=m Fueling around with glycogen: the implications of muscle phosphorylase b kinase deficiency. therapeutic application,unassigned 1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20080404&form=6&db=m Muscle phosphorylase b kinase deficiency revisited. unassigned - 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21911307&form=6&db=m Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22238410&form=6&db=m Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease? causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24389071&form=6&db=m Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27399985&form=6&db=m Substrate kinetics in patients with disorders of skeletal muscle metabolism. causal interaction,diagnostic usage,unassigned 1,3,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28283841&form=6&db=m Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency. causal interaction,diagnostic usage,ongoing research,unassigned 2,1,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32303402&form=6&db=m No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency. ongoing research,therapeutic application,unassigned 3,1,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32697758&form=6&db=m Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene. causal interaction,unassigned 4,0 2.7.11.19 phosphorylase kinase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34117828&form=6&db=m PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia only. diagnostic usage,unassigned 1,0 2.7.11.19 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8148269&form=6&db=m Elevated phosphorylase kinase activity in psoriatic epidermis: correlation with increased phosphorylation and psoriatic activity. diagnostic usage,ongoing research,unassigned 3,3,0 2.7.11.19 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11069500&form=6&db=m Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. diagnostic usage,ongoing research,unassigned 4,2,0 2.7.11.19 Psoriasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26364215&form=6&db=m An evaluation of indirubin analogues as phosphorylase kinase inhibitors. causal interaction,therapeutic application,unassigned 1,2,0 2.7.11.19 pullulanase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10821216&form=6&db=m The molecular background of glycogen metabolism disorders. causal interaction,ongoing research,unassigned 4,3,0 2.7.11.19 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6369914&form=6&db=m Proteolytic activity in patients with hypercatabolic renal failure. causal interaction,therapeutic application,unassigned 4,4,0 2.7.11.19 Renal Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7019564&form=6&db=m Evidence for the participation of proteases on protein catabolism during hypercatabolic renal failure. causal interaction,diagnostic usage,ongoing research,therapeutic application 4,4,3,1 2.7.11.19 Respiratory Insufficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6184993&form=6&db=m In vitro inhibition of protein catabolism by alpha 2-macroglobulin in plasma from a patient with posttraumatic acute renal failure. causal interaction,diagnostic usage,unassigned 1,2,0 2.7.11.19 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1446241&form=6&db=m Effect of starvation on glycogen and glucose metabolism in different areas of the rat brain. ongoing research,unassigned 2,0 2.7.11.19 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3421934&form=6&db=m Starvation of phosphorylase kinase deficient rats is accompanied by partial hepatic glycogen depletion. unassigned - 2.7.11.19 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8717429&form=6&db=m The association of phosphorylase kinase with membranes of rat liver smooth endoplasmic reticulum. unassigned - 2.7.11.19 Uremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6204101&form=6&db=m Role of proteases in hypercatabolic patients with renal failure. causal interaction,diagnostic usage,unassigned 1,3,0 2.7.11.19 Whooping Cough http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2903735&form=6&db=m Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes. ongoing research,unassigned 1,0